Zhejiang Starry Pharmaceutical Co.,Ltd.

SSE:603520.SS

10.42 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q4
Revenue 685.896545.708474.064683.41637.578561.237547.023517.971565.908754.164434.608425.169517.298689.266455.548491.022364.081320.672324.353430.569291.494323.104349.878341.584294.276256.282206.126231.023197.039159.327154.501200.839196.272160.498154.096187.348171.004203.488129.001157.835205.336198.605
Cost of Revenue 563.483475.873373.146558.473499.544440.745405.831378.687449.8598.531353.665311.146355.447467.482294.947286.544202.969205.799180.201220.18159.548178.028200.389192.5178.744158.703115.183135.214120.964109.37388.378125.48121.05997.99495.107118.808104.333125.49481.42100.336129.921161.188
Gross Profit 122.41369.835100.918124.937138.034120.492141.192139.283116.107155.63380.943114.024161.852221.785160.601204.478161.112114.873144.152210.388131.945145.075149.489149.084115.53297.57990.94495.80976.07549.95466.12375.35975.21262.50358.98968.5466.67177.99347.58157.49975.41537.418
Gross Profit Ratio 0.1780.1280.2130.1830.2160.2150.2580.2690.2050.2060.1860.2680.3130.3220.3530.4160.4430.3580.4440.4890.4530.4490.4270.4360.3930.3810.4410.4150.3860.3140.4280.3750.3830.3890.3830.3660.390.3830.3690.3640.3670.188
Reseach & Development Expenses 19.14643.07834.68824.29332.12524.80638.37930.32334.84537.13633.70133.80427.96943.01828.54928.20224.81231.1520.54922.63213.51226.60512.81521.60416.75113.59926.4539.30712.85770.99613.15922.101049.062022.725040.392016.94200
General & Administrative Expenses 29.671-46.59967.946-3.62730.396-40.13864.840.73125.808-37.51772.99-1.77935.107-43.35763.0852.69530.398-33.16343.21-3.90428.163-39.95633.3920.52522.468-9.56616.138-16.96729.692-61.91533.364-13.22725.519-66.46933.004-12.73323.862-54.69928.88226.11117.9460
Selling & Marketing Expenses 27.04924.8233.68838.37525.5734.85822.27323.04118.95414.24220.74729.9355.89111.741.4936.5192.8463.9612.6493.8651.9035.6592.5872.2923.4854.6312.6582.851.6552.952.0342.6472.389.6841.9477.7121.7234.3322.3652.9051.9620
SG&A 56.72-21.779101.63468.28361.16860.46587.11323.77344.763-23.27593.73728.15640.998-31.61764.5789.21433.244-29.20245.859-0.03930.066-34.29735.9792.81725.953-4.93518.796-14.11731.346-58.96635.398-10.57927.899-56.78534.951-5.0225.585-50.36831.24729.01619.9080
Other Expenses 30.531118.572-23.349-3.967-1.856-19.197-0.474-1.5241.85276.322-37.40232.098-2.686-0.404-0.712-2.637-0.62113.106-0.986-1.369-0.988-5.835-1.504-0.427-0.653-2.126-3.908-1.083-0.995-9.3364.095-1.1863.0471.8272.8320.4560.404-2.7760.4931.680.5960
Operating Expenses 106.398139.871112.97296.54495.149104.46891.09488.05481.4690.18390.03694.05766.2883.65759.24672.3452.60166.0666.39259.28844.32960.21349.58857.51345.72258.22246.77937.14333.12534.13738.50134.51230.16941.38235.86137.2326.65541.31631.81530.19421.6161.746
Operating Income 16.015-70.0370.39728.39342.88516.0248.52225.0979.901-99.051-9.093-17.30593.575123.43374.711121.69479.92837.57372.467121.8662.03546.49162.00468.95652.86711.80332.89352.67329.46122.60217.57932.29334.39915.02618.23727.98932.16626.0847.85418.75540.98737.418
Operating Income Ratio 0.023-0.1280.0010.0420.0670.0290.0160.0480.017-0.131-0.021-0.0410.1810.1790.1640.2480.220.1170.2230.2830.2130.1440.1770.2020.180.0460.160.2280.150.1420.1140.1610.1750.0940.1180.1490.1880.1280.0610.1190.20.188
Total Other Income Expenses Net 0.242-1.937-11.45-19.285-23.131-2.171-0.474-1.5240.792-2.635-36.132-15.6862.918-0.404-24.203-9.69-26.49313.106-11.599-26.316-26.06-38.85-38.447-20.214-17.597-17.495-15.18-1.083-14.484-6.74-7.309-5.643-9.19-4.747-2.343-2.692-7.449-6.136-7.807-7.56-12.741-1.746
Income Before Tax 16.257-71.974-11.05310.8619.7549.2168.04823.5729.7-103.301-45.162-9.26292.32123.02973.999119.05779.30750.6871.481120.49161.04740.65660.568.52952.2139.67728.98551.58928.46615.86220.31230.25237.06516.4620.78527.63632.56727.1387.95917.21741.05835.671
Income Before Tax Ratio 0.024-0.132-0.0230.0160.0310.0160.0150.0460.017-0.137-0.104-0.0220.1780.1780.1620.2420.2180.1580.220.280.2090.1260.1730.2010.1770.0380.1410.2230.1440.10.1310.1510.1890.1030.1350.1480.190.1330.0620.1090.20.18
Income Tax Expense 1.99-13.6261.078-1.5125.992-1.0263.822-2.3720.374-2.222-5.0278.0715.69811.8918.10630.92614.7016.21510.19321.91611.7761.22114.50313.7629.491-1.6899.6648.7366.4674.6194.4174.4678.5644.2055.3515.936.0586.682-0.618.395.4435.109
Net Income 14.344-58.075-13.92210.61612.2834.9154.04225.7089.568-101.079-40.135-17.33480.24104.25963.84891.07664.57140.2858.76594.0345.65532.89844.31152.29740.8258.88219.81942.81822.15812.94115.68326.43528.05913.8615.52621.55725.17819.227.6977.62534.40230.563
Net Income Ratio 0.021-0.106-0.0290.0160.0190.0090.0070.050.017-0.134-0.092-0.0410.1550.1510.140.1850.1770.1260.1810.2180.1570.1020.1270.1530.1390.0350.0960.1850.1120.0810.1020.1320.1430.0860.1010.1150.1470.0940.060.0480.1680.154
EPS 0.03-0.131-0.0320.0240.0360.0140.0120.0750.028-0.3-0.17-0.0710.240.30.260.370.190.170.180.40.140.140.130.240.120.0370.0820.180.0660.0550.0470.110.0840.0590.0470.120.10.10.0290.0430.140.12
EPS Diluted 0.03-0.131-0.0320.0240.0360.0140.0120.0750.028-0.3-0.17-0.0710.240.30.260.370.190.170.180.40.140.140.130.240.120.0370.0820.180.0660.0550.0470.110.0840.0590.0470.120.10.10.0290.0430.140.12
EBITDA 40.224-44.8888.95689.284102.93881.13487.63794.13680.917-28.66422.66556.108147.667177.714133.002177.125138.632110.774130.103171.341110.81782.13999.706114.70798.74656.21744.16561.48561.62822.36843.96240.46763.07338.31123.12830.71840.01648.49229.89438.60266.53550.153
EBITDA Ratio 0.059-0.0820.0190.1310.1610.1450.160.1820.143-0.0380.0520.1320.2850.2580.2920.3610.3810.3450.4010.3980.380.2540.2850.3360.3360.2190.2140.2660.3130.140.2850.2010.3210.2390.150.1640.2340.2380.2320.2450.3240.253